Aqtual
United States · $16.0M raised
- Business Model
- B2B
- Website
- aqtual.com
- Total Funding
- $16.0M
- Last Round
- $16.0M Series AOct 2023
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round for this company. The full record is or through the API.
About
Aqtual develops precision-medicine products for chronic inflammatory diseases and oncology. The company combines proprietary biochemistry, data science, and novel technology to analyze circulating chromatin and cell-free DNA from a single blood draw. Its work aims to produce blood tests that detect and monitor disease and help stratify patients for treatment decisions across multiple therapeutic areas.
Summary
Aqtual is a Biotech company based in United States. It has raised $16.0M in total across 1 round, most recently a $16.0M Series A round in Oct 2023.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Oct 2023
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/aqtual"><img src="https://indexed.vc/api/badge/company/aqtual" alt="Aqtual on Indexed.vc" width="260" height="76" /></a>